Congestive heart failure in elderly patients: controlled study of delapril versus captopril. (Q53642030)

16 May 2018

title

Congestive heart failure in elderly patients: controlled study of delapril versus captopril. (English)

1 reference

16 May 2018

main subject

heart failure

0 references

congestive heart failure

1 reference

D Acanfora

1

1 reference

16 May 2018

T Lanzillo

2

1 reference

16 May 2018

A Papa

3

1 reference

16 May 2018

G Longobardi

4

1 reference

16 May 2018

G Furgi

5

1 reference

16 May 2018

C Rengo

6

1 reference

16 May 2018

E Melillo

7

1 reference

16 May 2018

F Rengo

8

1 reference

16 May 2018

language of work or name

English

0 references

publication date

1 June 1995

1 reference

16 May 2018

American Journal of Cardiology

published in

1 reference

16 May 2018

volume

75

1 reference

16 May 2018

issue

18

1 reference

16 May 2018

page(s)

37F-43F

1 reference

16 May 2018

Prevalence and mortality rate of congestive heart failure in the United States

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980513-X

Pathophysiology and current therapy of congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980513-X

Maintenance of the inotropic effect of digoxin on long-term treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980513-X

Heart failure in outpatients: a randomized trial of digoxin versus placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980513-X

Maintenance digoxin after an episode of heart failure: placebo-controlled trial in outpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980513-X

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980513-X

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980513-X

Comparison of captopril and enalapril in patients with severe chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980513-X

Effect of vasodilators on survival in chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980513-X

Effects of xamoterol, a beta 1 adrenoceptor partial agonist, in patients with ischaemic dysfunction of the left ventricle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980513-X

Prognosis of congestive heart failure in elderly patients with normal versus abnormal left ventricular systolic function associated with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980513-X

Vasodilator therapy for heart failure. The influence of impedance on left ventricular performance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980513-X

Changes in cardiovascular function with aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980513-X

Heart failure with normal systolic function. Update of prevalence, differential diagnosis, prognosis, and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980513-X

Congestive heart failure with normal systolic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980513-X

A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980513-X

Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980513-X

Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980513-X

A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980513-X

Exercise capacity in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980513-X

Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980513-X

Regional blood flow supply and demand in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980513-X

Abnormalities of skeletal muscle in patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980513-X

Blood flow distribution within skeletal muscle during exercise in the presence of chronic heart failure: effect of milrinone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980513-X

Exercise conditioning in the elderly coronary patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980513-X

Assessment of quality of life as observed from the baseline data of the Studies of Left Ventricular Dysfunction (SOLVD) trial quality-of-life substudy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980513-X

Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980513-X

Characteristics of a new angiotensin converting enzyme inhibitor: delapril

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980513-X

10.1016/S0002-9149(99)80513-X

7 January 2021

Identifiers

DOI

1 reference

16 May 2018

1 reference

16 May 2018